Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

QuidelOrtho Corp (QDEL.O)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (US$)	Price Target (US$)	Rating
2022-03-30	112.80	-	No Rating
2022-07-19	105.20	86.00	Sell
2022-10-14	76.29	86.00	Neutral
2022-11-03	87.52	93.00	Neutral
2023-02-21	89.70	99.00	Neutral
2023-05-17	87.65	98.00	Neutral
2023-11-17	66.25	70.00	Neutral
2024-03-03	45.53	42.00	Sell
2024-03-28	47.94	-	No Rating
2024-09-18	46.23	50.00	Neutral
2024-11-07	38.85	43.00	Neutral
2025-02-12	39.94	45.00	Neutral
2025-05-08	36.46	29.00	Neutral

Disclosures

UBS Securities LLC makes a market in the securities and/or ADRs of this company.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.